top of page

Regulatory Blog

The Regulatory News you Need to Know,Share & Grow

Mar 23, 20221 min read

USFDA's recent Guidance on Biologics: Ophthalmic Products & Development of (CAR) T Cell Products

1. Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR This guidance is intended to provide information to applicants...

bottom of page